---
figid: PMC9494602__ol-24-04-13499-g02
pmcid: PMC9494602
image_filename: ol-24-04-13499-g02.jpg
figure_link: /pmc/articles/PMC9494602/figure/f3-ol-24-04-13499/
number: Figure 3
figure_title: ''
caption: miR-29a-3p inhibits the Wnt/β-catenin pathway in NSCLC cells. Western blotting
  was used to measure the expression of Wnt3a and β-catenin in A549 cells. A549 cells
  were transfected with NC, miR-29a-3p mimic or miR-29a-3p inhibitor. *P<0.05, **P<0.01
  vs. control group. NC, negative control; NSCLC, non-small cell lung cancer; miR,
  microRNA.
article_title: miR-29a-3p inhibits the malignant characteristics of non-small cell
  lung cancer cells by reducing the activity of the Wnt/β-catenin signaling pathway.
citation: Kang Zhang, et al. Oncol Lett. 2022 Oct;24(4):379.
year: '2022'

doi: 10.3892/ol.2022.13499
journal_title: Oncology Letters
journal_nlm_ta: Oncol Lett
publisher_name: D.A. Spandidos

keywords:
- non-small cell lung cancer
- microRNA29a-3p
- Wnt/β-catenin pathway
- proliferation
- migration
- invasion

---
